Global Biosimilar Drug Market Growth 2025-2031

Global Biosimilar Drug Market Growth 2025-2031

The global Biosimilar Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine.

A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilar drug is officially approved versions of original “innovator” products, and can be manufactured when the original product"s patent expires.

In China, Biosimilar Drug key players include CP Guojian Pharma, Biotech Pharma, Celgen Pharma, etc. Global top three manufacturers hold a share over 70%.

East China is the largest market, with a share over 70%, followed by North China, with a share about 15 percent.

In terms of product, Tablets is the largest segment, with a share over 65%. And in terms of application, the largest application is Ankylosing Spondylitis, followed by Rheumatoid Arthrtis, Tumor, Cardiovascular, etc.

LP Information, Inc. (LPI) ' newest research report, the “Biosimilar Drug Industry Forecast” looks at past sales and reviews total world Biosimilar Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Biosimilar Drug sales for 2025 through 2031. With Biosimilar Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biosimilar Drug industry.

This Insight Report provides a comprehensive analysis of the global Biosimilar Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biosimilar Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biosimilar Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biosimilar Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biosimilar Drug.

This report presents a comprehensive overview, market shares, and growth opportunities of Biosimilar Drug market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Injection
Tablets
Other Types

Segmentation by Application:
Ankylosing Spondylitis
Tumor
Rheumatoid Arthrtis
Cardiovascular
Other Application

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
CP Guojian Pharma
Biotech Pharma
Celgen Pharma
Henlius
Amgen
Eli Lilly
Sandoz
Changchun High Tech
Innovent

Key Questions Addressed in this Report

What is the 10-year outlook for the global Biosimilar Drug market?

What factors are driving Biosimilar Drug market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Biosimilar Drug market opportunities vary by end market size?

How does Biosimilar Drug break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.